JAZZ · NASDAQ · Biotechnology

Jazz Pharmaceuticals (JAZZ)

Develops rare-disease medicines across sleep, epilepsy and oncology.

$240.57
After hours0.00 (0.00%)
At close$240.57(−0.37%)
  1. Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?

    Zacks Investment ResearchMarket move